These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5122998)

  • 1. [A study of the immunological competence of lymphocytes in patients with proliferative diseases of hemopoietic tissue].
    Loginskiĭ VE; Dudykevich GB
    Vrach Delo; 1971 Jul; 7():105-8. PubMed ID: 5122998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological classification of lymphoproliferative conditions].
    Froland SS
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2220-3. PubMed ID: 4531116
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunophenotyping of lymphoid cells].
    Béné MC; Faure GC
    Ann Biol Clin (Paris); 1993; 51(9):793-800. PubMed ID: 8166392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold non HLA lymphocyte cytotoxins in monoclonal gammopathies.
    Prou O; Muller JY; Fine JM
    Tissue Antigens; 1981 May; 17(5):546-8. PubMed ID: 6977891
    [No Abstract]   [Full Text] [Related]  

  • 5. The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
    Larsen TS; Christensen JH; Hasselbalch HC; Pallisgaard N
    Br J Haematol; 2007 Mar; 136(5):745-51. PubMed ID: 17313377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometriosis and autologous lymphocyte activation by endometrial cells. Are lymphocytes or endometrial cell defects responsible?
    Helvacioglu A; Aksel S; Peterson RD
    J Reprod Med; 1997 Feb; 42(2):71-5. PubMed ID: 9058340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation markers of lymphocytes as indicators of immune system dysregulation in inflammation].
    Poriadin GV; Salmasi ZhM; Kazimiskiĭ AN
    Patol Fiziol Eksp Ter; 2006; (1):2-7. PubMed ID: 16607883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reappraisal of the "myeloproliferative disease" concept.
    Gilbert HS
    Mt Sinai J Med; 1970; 37(4):426-35. PubMed ID: 5311165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
    Loni C; Ricci S; Azzarà A; Bertoncini G
    Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consumption of phytohemagglutinin by cultured lymphocytes from normal subjects and from patients with lympho-proliferative diseases].
    Tognella S; Del Giacco GS; Mantovani G; Manconi PE; Grifoni V
    Boll Soc Ital Biol Sper; 1970 Mar; 46(6):311-5. PubMed ID: 5458661
    [No Abstract]   [Full Text] [Related]  

  • 11. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
    Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
    Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte function in anergic patients.
    Rode HN; Christou NV; Bubenik O; Superina R; Gordon J; Meakins JL; MacLean LD
    Clin Exp Immunol; 1982 Jan; 47(1):155-61. PubMed ID: 6212172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of active and latent Epstein-Barr virus and human herpevirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases.
    Krueger GR; Kudlimay D; Ramon A; Klueppelberg U; Schumacher K
    In Vivo; 1994; 8(4):533-42. PubMed ID: 7893980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder.
    Townsend W; Cross NC; Waghorn K; Somana K; Ramsay A; Thomson K; Peggs K
    Bone Marrow Transplant; 2009 Aug; 44(3):197-9. PubMed ID: 19234514
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes.
    Breit SN; Luckhurst E; Penny R
    J Immunol; 1983 Feb; 130(2):681-6. PubMed ID: 6600250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3-/HLA-DR+, CD3+/HLA-DR+ cell levels and PHA stimulation of lymphocytes obtained from women with recurrent spontaneous abortions and subjected to partner's lymphocyte immunization.
    Wilczyński J; Sułowska Z; Malinowski A; Zeman K; Szpakowski M; Tchórzewski H; Podciechowski L
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):289-94. PubMed ID: 9523003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation sensitivity and proliferative recovery of hemopoietic stem cells in weanling as compared to adult mice.
    Fred SS; Smith WW
    Radiat Res; 1967 Oct; 32(2):314-26. PubMed ID: 6051478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phenotypic and functional analysis of blood lymphocytes and pathological focus in patients with pulmonary tuberculosis].
    Kosmiadi GA; Abramova ZP; Gergert VIa; Titiukhina MV
    Probl Tuberk; 1995; (2):42-3. PubMed ID: 7777464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal fluid lymphocytes from a subgroup of multiple sclerosis patients respond to mycobacterial antigens.
    Birnbaum G; Kotilinek L; Albrecht L
    Ann Neurol; 1993 Jul; 34(1):18-24. PubMed ID: 8517675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloproliferative disease in the cat, associated with C-type leukovirus particles in bone marrow.
    Schalm OW; Theilen GH
    J Am Vet Med Assoc; 1970 Dec; 157(11):1686-96. PubMed ID: 5530371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.